Neurology, ophthalmology, orl
| (30 dazwischenliegende Versionen von einem Benutzer werden nicht angezeigt) | |||
| Zeile 1: | Zeile 1: | ||
{{pnc}} | {{pnc}} | ||
| − | {{ | + | {{ft|D}} |
| − | + | *'''[[Cerebral embolism]]''' | |
| − | + | *'''[[Cerebral Haemorrhage]]''' | |
| − | + | *'''[[Smell and taste disorder]]''' | |
| − | + | *'''[[Brain infection Neurotropism]]''' | |
| − | + | *'''[[Guillain-Barre Syndrome]]''' | |
| − | + | *'''[[Autoimmune Neuropathies]]''' | |
| − | + | *'''[[Neurology Reviews and Multitopic]]''' | |
| − | + | *'''[[The morbid survivor]]''' late sequelae | |
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | *'''[[Eye - Conjunctivitis]]''' | |
| − | + | *'''[[Eye - Reviews and Multitopic]]''' | |
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | *'''[[ORL - any]]''' | |
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | {{tp|p= | + | {{tp|p=32415003|t=2020. Do SARS-CoV2 viral proteins have neuromodulatory properties?|pdf=|usr=007}} |
| − | {{ | + | {{tp|p=32490972|t=2020. COVID-19 and the eye: how much do we really know? A best evidence review.|pdf=|usr=007}} |
| + | {{tp|p=32443834|t=2020. Specific EEG Encephalopathy Pattern in SARS-CoV-2 Patients.|pdf=|usr=007}} | ||
| + | {{ttp|p=32348111|t=ä. Is the Collapse of the Respiratory Center in the Brain Responsible for Respiratory Breakdown in COVID-19 Patients?|pdf=|usr=}} | ||
| + | {{tp|p=32322822|t=ä. THREE INSIGHTS ON PSYCHONEUROIMMUNOLOGY OF MOOD DISORDERS TO BE TAKEN FROM THE COVID-19 PANDEMIC |pdf=|usr=}} | ||
| + | {{tp|p=32328364|t=ä. Neurological Complications of Coronavirus Disease (COVID-19): Encephalopathy |pdf=|usr=}} | ||
| + | {{tp|p=32370982|t=ä. Ensuring mental health care during the SARS-CoV-2 epidemic in France: a narrative review |pdf=|usr=}} | ||
| + | {{tp|p=32363146|t=2020. COVID-19 Presenting with Seizures |pdf=|usr=}} | ||
| + | {{tp|p=32307298|t=ä. Severe cerebral involvement in adult-onset hemophagocytic lymphohistiocytosis |pdf=|usr=}} | ||
{{tp|p=32232433|t=2020. Characteristics of Ocular Findings of Patients With Coronavirus Disease 2019 (COVID-19) in Hubei Province, China |pdf=|usr=}} | {{tp|p=32232433|t=2020. Characteristics of Ocular Findings of Patients With Coronavirus Disease 2019 (COVID-19) in Hubei Province, China |pdf=|usr=}} | ||
| − | {{tp|p= | + | {{tp|p=32344366|t=2020. Focal status epilepticus as unique clinical feature of COVID-19: A case report |pdf=|usr=}} |
| − | {{tp|p= | + | {{tp|p=32478706|t=2020. Severe COVID-19 Cases: Is Respiratory Distress Partially Explained by Central Nervous System Involvement?|pdf=|usr=007}} |
| − | {{tp|p= | + | {{tp|p=32374367|t=ä. Delirium: a missing piece in the COVID-19 pandemic puzzle |pdf=|usr=}} |
| − | {{tp|p= | + | {{tp|p=32333819|t=2020. COVID-19: what if the brain had a role in causing the deaths?|pdf=|usr=}} |
| − | {{tp|p= | + | {{ttp|p=32301553|t=2020. Lack of dyspnea in patients with Covid-19: another neurological conundrum?|pdf=|usr=}} |
| + | {{ttp|p=32246784|t=ä. An alteration of the dopamine synthetic pathway is possibly involved in the pathophysiology of COVID?19 |pdf=|usr=}} | ||
| + | {{tp|p=32246782|t=2020. Respiratory failure alone does not suggest central nervous system invasion by SARS-CoV-2 |pdf=|usr=}} | ||
| + | {{tp|p=32291797|t=2020. SARS-CoV-2: At the Crossroad Between Aging and Neurodegeneration |pdf=|usr=}} | ||
| + | {{ttp|p=32388138|t=2020. Hypothesized behavioral host manipulation by SARS-CoV2/COVID-19 infection |pdf=|usr=}} | ||
| + | {{tp|p=32342265|t=ä. Coronavirus disease 2019 and obstructive sleep apnea syndrome |pdf=|usr=}} | ||
| + | {{tp|p=32457227|t=2020. COVID-19-related acute necrotizing encephalopathy with brain stem involvement in a patient with aplastic anemia.|pdf=|usr=007}} | ||
| + | {{tp|p=32390132|t=2020. Trombosis venosa cerebral e infeccion por SARS-CoV-2.|pdf=|usr=007}} | ||
| + | {{tp|p=32482781|t=2020. Acute disseminated encephalomyelitis after SARS-CoV-2 infection.|pdf=|usr=007}} | ||
| + | {{tp|p=32461235|t=2020. Guillain-Barre syndrome related to SARS-CoV-2 infection.|pdf=|usr=007}} | ||
| + | {{tp|p=32444427|t=2020. COVID-19-White matter and globus pallidum lesions: Demyelination or small-vessel vasculitis?|pdf=|usr=007}} | ||
| + | {{tp|p=32386285|t=2020. Anosmia as a presenting symptom of SARS-CoV-2 infection in healthcare workers - A systematic review of the literature, case series, and recommendations for clinical assessment and management.|pdf=|usr=007}} | ||
| + | {{tp|p=32352450|t=2020. Sniffing out the evidence; It's now time for public health bodies recognize the link between COVID-19 and smell and taste disturbance.|pdf=|usr=007}} | ||
| + | {{tp|p=32463395|t=2020. The involvement of the central nervous system in patients with COVID-19.|pdf=|usr=007}} | ||
| + | {{tp|p=32355007|t=2020. The mystery of the pandemic's 'happy hypoxia'.|pdf=|usr=007}} | ||
| + | {{tp|p=32286214|t=2020. [Possible unregistered SARS-CoV-2 infection in a young man with anosmia and ageusia].|pdf=|usr=007}} | ||
| + | {{tp|p=32400371|t=2020. [Anosmia and ageusia as primary symptoms of COVID-19].|pdf=|usr=007}} | ||
| + | {{tp|p=32476394|t=2020. Otorinolaringologicheskie aspekty techeniya zabolevaniya u detei, infitsirovannykh virusom SARS-CoV-2.|pdf=|usr=007}} | ||
| + | {{tp|p=32468632|t=2020. Olfactory dysfunction in recovered COVID-19 patients.|pdf=|usr=007}} | ||
| + | {{tp|p=32512352|t=2020. Affective psychosis after COVID-19 infection in a previously healthy patient: a case report.|pdf=|usr=007}} | ||
| + | {{tp|p=32442268|t=2020. Stroke in a young COVID -19 patient.|pdf=|usr=007}} | ||
| + | {{tp|p=32484418|t=2020. Focal Cerebral Arteriopathy in a COVID-19 Pediatric Patient.|pdf=|usr=007}} | ||
| + | {{tp|p=32437314|t=2020. COVID-19 -associated Diffuse Leukoencephalopathy and Microhemorrhages.|pdf=|usr=007}} | ||
| + | {{tp|p=32437313|t=2020. Imaging in Neurological Disease of Hospitalized COVID-19 Patients: An Italian Multicenter Retrospective Observational Study.|pdf=|usr=007}} | ||
| + | {{tp|p=32407258|t=2020. COVID-19-Associated Leukoencephalopathy.|pdf=|usr=007}} | ||
| + | {{tp|p=32510821|t=2020. Oral cavity lesions as a manifestation of the novel virus (COVID-19): a letter-to-editor.|pdf=|usr=007}} | ||
| + | {{tp|p=32506730|t=2020. Oral Manifestations in Coronavirus Disease 2019 (COVID-19).|pdf=|usr=007}} | ||
| + | {{tp|p=32506662|t=2020. Necrotizing periodontal disease: oral manifestation of COVID-19.|pdf=|usr=007}} | ||
| + | {{tp|p=32419568|t=2020. Orbital cellulitis, sinusitis and intracranial abnormalities in two adolescents with COVID-19.|pdf=|usr=007}} | ||
| + | {{tp|p=32453685|t=2020. Acute Cerebral Stroke with Multiple Infarctions and COVID-19, France, 2020.|pdf=|usr=007}} | ||
| + | {{tp|p=32490966|t=2020. Neurological complications in patients with SARS-CoV-2 infection: a systematic review.|pdf=|usr=007}} | ||
| + | {{tp|p=32469246|t=2020. Psychophysical Olfactory Tests and Detection of COVID-19 in Patients With Sudden Onset Olfactory Dysfunction: A Prospective Study.|pdf=|usr=007}} | ||
| + | {{tp|p=32436441|t=2020. Anosmia Is a Key Symptom of COVID-19 Infection and Should Be Used as a Diagnostic Tool.|pdf=|usr=007}} | ||
| + | {{tp|p=32423359|t=2020. Subjective Changes in Smell and Taste During the COVID-19 Pandemic: A National Survey-Preliminary Results.|pdf=|usr=007}} | ||
| + | {{tp|p=32423285|t=2020. Aggregate Prevalence of Chemosensory and Sinonasal Dysfunction in SARS-CoV-2 and Related Coronaviruses.|pdf=|usr=007}} | ||
| + | {{tp|p=32502296|t=2020. SARS-CoV2 as a potential trigger of neurodegenerative diseases.|pdf=|usr=007}} | ||
| + | {{tp|p=32502289|t=2020. SARS-CoV-2 as a trigger of neurodegeneration: thinking ahead.|pdf=|usr=007}} | ||
| + | {{tp|p=32348051|t=2020. Anosmie et COVID-19.|pdf=|usr=007}} | ||
| + | {{tp|p=32501861|t=2020. Considering the potential for an increase in chronic pain following the COVID-19 pandemic.|pdf=|usr=007}} | ||
| + | {{tp|p=32404789|t=2020. Neonatal Early-Onset Infection With SARS-CoV-2 in a Newborn Presenting With Encephalitic Symptoms.|pdf=|usr=007}} | ||
| + | {{tp|p=32468450|t=2020. New clinical manifestation of COVID-19 related Guillain-Barre syndrome highly responsive to intravenous immunoglobulins: two Italian cases.|pdf=|usr=007}} | ||
| + | {{tp|p=32444493|t=2020. Clinical characteristics and outcomes of inpatients with neurologic disease and COVID-19 in Brescia, Lombardy, Italy.|pdf=|usr=007}} | ||
| + | {{tp|p=32444492|t=2020. Bilateral transient olfactory bulbs edema during COVID-19-related anosmia.|pdf=|usr=007}} | ||
| + | {{tp|p=32439822|t=2020. Pearls and Oy-sters: Facial nerve palsy as a neurological manifestation of Covid-19 infection.|pdf=|usr=007}} | ||
| + | {{tp|p=32439821|t=2020. Generalized myoclonus in COVID-19.|pdf=|usr=007}} | ||
| + | {{tp|p=32487714|t=2020. Cranial Neuropathies and COVID-19: Neurotropism and Autoimmunity.|pdf=|usr=007}} | ||
| + | {{tp|p=32482845|t=2020. Neurologic manifestations in hospitalized patients with COVID-19: The ALBACOVID registry.|pdf=|usr=007}} | ||
| + | {{tp|p=32424429|t=2020. Neurologically Devastating Intraparenchymal Hemorrhage in COVID-19 Patients on Extracorporeal Membrane Oxygenation: A Case Series.|pdf=|usr=007}} | ||
| + | {{tp|p=32496534|t=2020. Letter: Thrombotic Neurovascular Disease in COVID-19 Patients.|pdf=|usr=007}} | ||
| + | {{tp|p=32490520|t=2020. Letter: Hemorrhagic Conditions Affecting the Central Nervous System in COVID-19 Patients.|pdf=|usr=007}} | ||
| + | {{ttp|p=32392566|t=2020. The Hidden Face of Fear in the COVID-19 Era: The Amygdala Hijack.|pdf=|usr=007}} | ||
| + | {{tp|p=32487282|t=2020. Encephalopathy and Encephalitis Associated with Cerebrospinal Fluid Cytokine Alterations and Coronavirus Disease, Atlanta, Georgia, USA, 2020.|pdf=|usr=007}} | ||
| + | {{tp|p=32445201|t=2020. SARS-CoV-2-associated Guillain-Barre syndrome with dysautonomia.|pdf=|usr=007}} | ||
| + | {{tp|p=32505222|t=2020. Early evidence of pronounced brain involvement in fatal COVID-19 outcomes.|pdf=|usr=007}} | ||
| + | {{tp|p=32503883|t=2020. Defining causality in COVID-19 and neurological disorders.|pdf=|usr=007}} | ||
| + | {{tp|p=32507577|t=2020. COVID-19 and Cerebral Hemorrhage: Proposed Mechanisms.|pdf=|usr=007}} | ||
| + | {{tp|p=32458578|t=2020. COVID-19 encephalopathy masquerading as substance withdrawal.|pdf=|usr=007}} | ||
| + | {{tp|p=32453517|t=2020. More on Neurologic Features in Severe SARS-CoV-2 Infection. Reply.|pdf=|usr=007}} | ||
| + | {{tp|p=32453516|t=2020. More on Neurologic Features in Severe SARS-CoV-2 Infection.|pdf=|usr=007}} | ||
| + | {{tp|p=32453515|t=2020. More on Neurologic Features in Severe SARS-CoV-2 Infection.|pdf=|usr=007}} | ||
| + | {{tp|p=32497292|t=2020. Guillain-Barre Syndrome in a Patient with Minimal Symptoms of COVID-19 Infection.|pdf=|usr=007}} | ||
| + | {{tp|p=32432682|t=2020. Olfactory Dysfunction in COVID-19: Diagnosis and Management.|pdf=|usr=007}} | ||
| + | {{tp|p=32469387|t=2020. Neuropathogenesis and Neurologic Manifestations of the Coronaviruses in the Age of Coronavirus Disease 2019: A Review.|pdf=|usr=007}} | ||
| + | {{tp|p=32497288|t=2020. COVID-19 polyradiculitis in 24 patients without SARS-CoV-2 in the cerebro-spinal fluid.|pdf=|usr=007}} | ||
| + | {{tp|p=32504746|t=2020. SARS-CoV-2 RNA detection in tears and conjunctival secretions of COVID-19 patients with conjunctivitis.|pdf=|usr=007}} | ||
| + | {{tp|p=32427357|t=2020. Encephalopathy in patients with COVID-19: 'Causality or coincidence?'|pdf=|usr=007}} | ||
| + | {{tp|p=32418237|t=2020. Hypoxemia in COVID-19; Comment on: "The neuroinvasive potential of SARS - CoV2 may play a role in the respiratory failure of COVID-19 patients".|pdf=|usr=007}} | ||
| + | {{tp|p=32484990|t=2020. First Case of Focal Epilepsy Associated with SARS-Coronavirus-2.|pdf=|usr=007}} | ||
| + | {{tp|p=32451359|t=2020. Stroke and mechanical thrombectomy in patients with COVID-19: technical observations and patient characteristics.|pdf=|usr=007}} | ||
| + | {{tp|p=32492193|t=2020. Potential Neuroinvasive Pathways of SARS-CoV-2: Deciphering the Spectrum of Neurological Deficit Seen in Coronavirus Disease 2019 (COVID-19).|pdf=|usr=007}} | ||
| + | {{tp|p=32504100|t=2020. Ocular manifestations of coronavirus disease 2019.|pdf=|usr=007}} | ||
| + | {{tp|p=32437033|t=2020. Objective olfactory evaluation of self-reported loss of smell in a case series of 86 COVID-19 patients.|pdf=|usr=007}} | ||
| + | {{tp|p=32437022|t=2020. Olfactory and gustatory function impairment in COVID-19 patients: Italian objective multicenter-study.|pdf=|usr=007}} | ||
| + | {{tp|p=32507468|t=2020. Measuring grip strength in COVID-19: A simple way to predict overall frailty/impairment.|pdf=|usr=007}} | ||
| + | {{tp|p=32461325|t=2020. Anosmia and dysgeusia associated with SARS-CoV-2 infection: an age-matched case-control study.|pdf=|usr=007}} | ||
| + | {{tp|p=32406374|t=2020. Olfactory dysfunction in the COVID-19 outbreak.|pdf=|usr=007}} | ||
| + | {{tp|p=32505878|t=2020. Patients with COVID-19 and neurological manifestations show undetectable SARS-CoV-2 RNA levels in the cerebrospinal fluid.|pdf=|usr=007}} | ||
| + | {{tp|p=32412510|t=2020. Neurological manifestations of COVID-19.|pdf=|usr=007}} | ||
| + | {{tp|p=32398625|t=2020. Coincidence of COVID-19 Infection and Smell: Taste Perception Disorders.|pdf=|usr=007}} | ||
| + | {{tp|p=32505431|t=2020. Neuroimmune correlates of the nervous system involvement of COVID-19: A commentary.|pdf=|usr=007}} | ||
| + | {{tp|p=32505432|t=2020. Does COVID-19 cause axonal GBS?|pdf=|usr=007}} | ||
| + | {{tp|p=32436835|t=2020. Isolated Anosmia as a Presentation of COVID-19: An Experience in a Referral Hospital.|pdf=|usr=007}} | ||
| + | {{tp|p=32408926|t=2020. Fallout from the Covid-19 pandemic - should we prepare for a tsunami of post viral depression?|pdf=|usr=007}} | ||
| + | {{tp|p=32501751|t=2020. EXPRESS: Brain ischemic and hemorrhagic complications of COVID-19.|pdf=|usr=007}} | ||
| + | {{tp|p=32497397|t=2020. Psychophysical olfactory testing in COVID-19: is smell function really impaired in nearly all patients?|pdf=|usr=007}} | ||
| + | {{tp|p=32496658|t=2020. Reply to: Psychophysical olfactory testing in COVID-19: Is smell function really impaired in nearly all patients?|pdf=|usr=007}} | ||
| + | {{tp|p=32503820|t=2020. Ocular Manifestations of COVID-19 (SARS-CoV-2): A Critical Review of Current Literature.|pdf=|usr=007}} | ||
| + | {{tp|p=32441248|t=2020. The impact of SARS-CoV-2 on sleep.|pdf=|usr=007}} | ||
| + | {{tp|p=32507123|t=2020. Self-reported anosmia and dysgeusia as key symptoms of COVID-19.|pdf=|usr=007}} | ||
| + | {{tp|p=32478675|t=2020. Headache is an important symptom in patients with coronavirus disease 2019 (COVID-19).|pdf=|usr=007}} | ||
| + | {{tp|p=32460415|t=2020. Dysphagia in COVID-19 -multilevel damage to the swallowing network?|pdf=|usr=007}} | ||
| + | {{tp|p=32433817|t=2020. Prolonged Confusional state as first manifestation of COVID-19.|pdf=|usr=007}} | ||
| + | {{tp|p=32503088|t=2020. A systematic review of neurological manifestations of SARS-CoV-2 infection: the devil is hidden in the details.|pdf=|usr=007}} | ||
| + | {{tp|p=32503084|t=2020. Miller-Fisher syndrome after SARS-CoV-2 infection.|pdf=|usr=007}} | ||
| + | {{tp|p=32503080|t=2020. Concomitant brain arterial and venous thrombosis in a COVID-19 patient.|pdf=|usr=007}} | ||
| + | {{tp|p=32492256|t=2020. How to support the quality of life of people living with cognitive disorders? A (k)new challenge in the post-Covid World.|pdf=|usr=007}} | ||
| + | {{tp|p=32478936|t=2020. SARS-CoV-2 and Guillain-Barre syndrome: AIDP variant with favorable outcome.|pdf=|usr=007}} | ||
| + | {{tp|p=32450718|t=2020. Ophthalmology and SARS-CoV-2: Blind toward those who fight blindness?|pdf=|usr=007}} | ||
| + | {{tp|p=32443166|t=2020. Letter to the Editor about the Beltran-Corbellini et al. publication :"Acute-onset smell and taste disorders in the context of Covid-19: a pilot multicenter PCR-based case-control study" (Eur J Neurol. 2020. doi: 10.1111/ene.14273.).|pdf=|usr=007}} | ||
| + | {{tp|p=32449247|t=2020. Reply to letter: Acute-onset smell and taste disorders in the context of Covid-19: a pilot multicenter PCR-based case-control study.|pdf=|usr=007}} | ||
| + | {{tp|p=32416028|t=2020. Neurological manifestations and neuro-invasive mechanisms of the severe acute respiratory syndrome coronavirus type 2.|pdf=|usr=007}} | ||
| + | {{tp|p=32468862|t=2020. L..: malignant MCA infarct in a patient with COVID 19 infection.|pdf=|usr=007}} | ||
| + | {{tp|p=32463454|t=2020. Alterations in smell or taste - Classic COVID-19?|pdf=|usr=007}} | ||
| + | {{tp|p=32436625|t=2020. Low risk of SARS-CoV-2 transmission through the ocular surface.|pdf=|usr=007}} | ||
| + | {{tp|p=32484130|t=2020. COVID-19 associated central nervous system vasculopathy.|pdf=|usr=007}} | ||
| + | {{tp|p=32474587|t=2020. COVID-19: Possible reasons for the increased prevalence of Olfactory and Gustatory dysfunction observed in European studies.|pdf=|usr=007}} | ||
| + | {{tp|p=32491829|t=2020. SARS-CoV-2 more than a respiratory virus: Its potential role in neuropathogenesis.|pdf=|usr=007}} | ||
| + | {{tp|p=32421258|t=2020. Ocular manifestations and clinical characteristics of 535 cases of COVID-19 in Wuhan, China: a cross-sectional study.|pdf=|usr=007}} | ||
| + | {{tp|p=32403983|t=2020. Neurotropic mechanisms in COVID-19 and their potential influence on neuropsychological outcomes in children.|pdf=|usr=007}} | ||
| + | {{tp|p=32468972|t=2020. Guillain-Barre syndrome with facial diplegia related to SARS-CoV-2 infection.|pdf=|usr=007}} | ||
| + | {{tp|p=32493536|t=2020. COVID-19 presenting with thalamic hemorrhage unmasking moyamoya angiopathy.|pdf=|usr=007}} | ||
| + | {{tp|p=32473022|t=2020. Coronavirus disease-2019 in pregnancy with neurological manifestations versus pregnancy with eclampsia: Need for liberal testing to rule out the masquerades.|pdf=|usr=007}} | ||
| + | {{tp|p=32420954|t=2020. Smell and taste dysfunction during the COVID-19 outbreak: a preliminary report.|pdf=|usr=007}} | ||
| + | {{tp|p=32413158|t=2020. Headaches During COVID-19: My Clinical Case and Review of the Literature.|pdf=|usr=008}} | ||
| + | {{tp|p=32470238|t=2020. Taste and smell as chemosensory dysfunctions in COVID-19 infection.|pdf=|usr=007}} | ||
| + | {{tp|p=32451564|t=2020. Temporare Hyposmie bei COVID-19-Patienten.|pdf=|usr=008}} | ||
| + | {{tp|p=32426230|t=2020. Encephalopathy and seizure activity in a COVID-19 well controlled HIV patient.|pdf=|usr=008}} | ||
| + | {{tp|p=32467191|t=2020. Brain Imaging Use and Findings in COVID-19: A Single Academic Center Experience in the Epicenter of Disease in the United States.|pdf=|usr=007}} | ||
| + | {{tp|p=32467190|t=2020. COVID-19-Associated Miller Fisher Syndrome: MRI Findings.|pdf=|usr=007}} | ||
| + | {{tp|p=32467189|t=2020. Surprise Diagnosis of COVID-19 following Neuroimaging Evaluation for Unrelated Reasons during the Pandemic in Hot Spots.|pdf=|usr=007}} | ||
| + | {{tp|p=32439646|t=2020. Hemorrhagic Posterior Reversible Encephalopathy Syndrome as a Manifestation of COVID-19 Infection.|pdf=|usr=007}} | ||
| + | {{tp|p=32409316|t=2020. Cerebrovascular Disease in COVID-19.|pdf=|usr=007}} | ||
| + | {{tp|p=32354715|t=2020. Neuroradiologists, Be Mindful of the Neuroinvasive Potential of COVID-19.|pdf=|usr=007}} | ||
| + | {{tp|p=32483943|t=2020. Episcleritis as an ocular manifestation in a patient with COVID-19.|pdf=|usr=007}} | ||
| + | {{tp|p=32514394|t=2020. Symmetrical polyneuropathy in coronavirus disease 2019 (COVID-19).|pdf=|usr=008}} | ||
| + | {{tp|p=32519260|t=2020. Thalassemic Child Presenting with Anosmia due to COVID-19.|pdf=|usr=008}} | ||
| + | {{tp|p=32461419|t=2020. Commentary: Exploring the transmission of COVID-19 through the ocular surface.|pdf=|usr=008}} | ||
| + | {{tp|p=32461418|t=2020. Presence of viral RNA of SARS-CoV-2 in conjunctival swab specimens of COVID-19 patients.|pdf=|usr=008}} | ||
| + | {{tp|p=32410112|t=2020. Contribution of anosmia and dysgeusia for diagnostic of COVID-19 in outpatients.|pdf=|usr=008}} | ||
| + | {{tp|p=32532937|t=2020. Neurologic aspects of covid-19: a concise review.|pdf=|usr=008}} | ||
| + | {{tp|p=32425285|t=2020. Retrospective Analysis of Smell and Taste Disturbances Associated with Dermatological Medications Reported to the United States Food and Drug Administration and Relevance to COVID-19 Infections.|pdf=|usr=008}} | ||
| + | {{tp|p=32535294|t=2020. Could sudden sensorineural hearing loss be the sole manifestation of COVID-19? An investigation into SARS-COV-2 in the etiology of sudden sensorineural hearing loss.|pdf=|usr=008}} | ||
| + | {{tp|p=32363809|t=2020. Smell and taste symptom-based predictive model for COVID-19 diagnosis.|pdf=|usr=008}} | ||
| + | {{tp|p=32410386|t=2020. Smell and taste alterations in Covid-19: a cross-sectional analysis of different cohorts.|pdf=|usr=008}} | ||
| + | {{tp|p=32395917|t=2020. Self-reported olfactory loss in COVID-19: is it really a favorable prognostic factor?|pdf=|usr=008}} | ||
| + | {{tp|p=32395913|t=2020. Reply to: Self-reported olfactory loss in COVID-19: is it really a favorable prognostic factor?|pdf=|usr=008}} | ||
| + | {{tp|p=32271490|t=2020. A primer on viral-associated olfactory loss in the era of COVID-19.|pdf=|usr=008}} | ||
| + | {{tp|p=32279441|t=2020. Association of chemosensory dysfunction and COVID-19 in patients presenting with influenza-like symptoms.|pdf=|usr=008}} | ||
| + | {{tp|p=32526392|t=2020. Oral mucosal lesions in a COVID-19 patient: new signs or secondary manifestations?|pdf=|usr=008}} | ||
| + | {{tp|p=32531341|t=2020. Ocular manifestations and viral shedding in tears of pediatric patients with coronavirus disease 2019: a preliminary report.|pdf=|usr=008}} | ||
| + | {{tp|p=32410788|t=2020. Facial diplegia, a possible atypical variant of Guillain-Barre Syndrome as a rare neurological complication of SARS-CoV-2.|pdf=|usr=008}} | ||
| + | {{tp|p=32456959|t=2020. The Ocular Manifestations and Transmission of COVID-19: Recommendations for Prevention.|pdf=|usr=008}} | ||
| + | {{tp|p=32453100|t=2020. Novel Coronavirus (COVID-19)-Associated Guillain-Barre Syndrome: Case Report.|pdf=|usr=008}} | ||
| + | {{tp|p=32519322|t=2020. Self-Reported Loss of Smell and Taste in SARS-CoV-2 Patients: Primary Care Data to Guide Future Early Detection Strategies.|pdf=|usr=008}} | ||
| + | {{tp|p=32425479|t=2020. MRI evaluation of the olfactory clefts in patients with SARS-CoV-2 infection revealed an unexpected mechanism for olfactory function loss.|pdf=|usr=008}} | ||
| + | {{ttp|p=32427468|t=2020. Autonomic Brain Centers and Pathophysiology of COVID-19.|pdf=|usr=008}} | ||
| + | {{tp|p=32524537|t=2020. A complication of coronavirus disease 2019: delirium.|pdf=|usr=008}} | ||
| + | {{tp|p=32430637|t=2020. COVID-19-associated meningoencephalitis complicated with intracranial hemorrhage: a case report.|pdf=|usr=008}} | ||
| + | {{tp|p=32412088|t=2020. Neurological Manifestations of COVID-19: A systematic review and current update.|pdf=|usr=008}} | ||
| + | {{tp|p=32466862|t=2020. Alteraciones del olfato en la COVID-19, revision de la evidencia e implicaciones en el manejo de la pandemia.|pdf=|usr=008}} | ||
| + | {{tp|p=32527987|t=2020. Potential mechanisms of hemorrhagic stroke in elderly COVID-19 patients.|pdf=|usr=008}} | ||
| + | {{tp|p=32519994|t=2020. Vertigo and hearing loss during the COVID-19 pandemic - is there an association?|pdf=|usr=008}} | ||
| + | {{tp|p=32414522|t=2020. Weakness and elevated creatinine kinase as the initial presentation of coronavirus disease 2019 (COVID-19).|pdf=|usr=008}} | ||
| + | {{tp|p=32506549|t=2020. COVID-19: A Global Threat to the Nervous System.|pdf=|usr=008}} | ||
| + | {{tp|p=32425470|t=2020. Altered Mental Status as a Novel Initial Clinical Presentation for COVID-19 Infection in the Elderly.|pdf=|usr=008}} | ||
| + | {{tp|p=32527141|t=2020. Prevalence and Recovery From Olfactory and Gustatory Dysfunctions in Covid-19 Infection: A Prospective Multicenter Study.|pdf=|usr=008}} | ||
| + | {{tp|p=32473756|t=2020. Neuroleptic malignant syndrome in patients with COVID-19.|pdf=|usr=008}} | ||
| + | {{tp|p=32425321|t=2020. Neurologic complications of COVID-19.|pdf=|usr=008}} | ||
| + | {{tp|p=32530597|t=2020. Happy Hypoxemia in COVID-19-A Neural Hypothesis.|pdf=|usr=008}} | ||
| + | {{tp|p=32531619|t=2020. Olfactory and gustatory dysfunctions in COVID-19. First reports of Latin-American ethnic patients.|pdf=|usr=008}} | ||
| + | {{tp|p=32527845|t=2020. Evolving Neuroimaging Findings during COVID-19.|pdf=|usr=008}} | ||
| + | {{tp|p=32527844|t=2020. Neurovascular Complications in COVID-19 Infection: Case Series.|pdf=|usr=008}} | ||
| + | {{tp|p=32527843|t=2020. Neuroimaging Findings in Patients with COVID-19.|pdf=|usr=008}} | ||
| + | {{tp|p=32527842|t=2020. Neurologic Involvement in COVID-19: Cause or Coincidence? A Neuroimaging Perspective.|pdf=|usr=008}} | ||
| + | {{tp|p=32388880|t=2020. Guillain-Barre syndrome during SARS-CoV-2 pandemic: A case report and review of recent literature.|pdf=|usr=008}} | ||
| + | {{tp|p=32395550|t=2020. 2019 novel coronavirus pneumonia with onset of dizziness: a case report.|pdf=|usr=008}} | ||
| + | {{tp|p=32418288|t=2020. Steroid-Responsive Encephalitis in Coronavirus Disease 2019.|pdf=|usr=008}} | ||
| + | {{tp|p=32395831|t=2020. Rapid Dissemination of Protocols for Managing Neurology Inpatients with COVID-19.|pdf=|usr=008}} | ||
| + | {{tp|p=32419756|t=2020. Alteration of Consciousness as Initial Presentation in COVID-19: Observation.|pdf=|usr=008}} | ||
| + | {{tp|p=32419755|t=2020. COVID-19 and Epilepsy.|pdf=|usr=008}} | ||
| + | {{tp|p=32419754|t=2020. COVID-19 and Underlying Cerebrovascular Disease: Analysis on Association.|pdf=|usr=008}} | ||
| + | {{tp|p=32419753|t=2020. COVID 19: Neuromuscular Manifestations.|pdf=|usr=008}} | ||
| + | {{tp|p=32419751|t=2020. 2019-NCoV: What Every Neurologist Should Know?|pdf=|usr=008}} | ||
| + | {{tp|p=32407609|t=2020. De Novo Status Epilepticus in patients with COVID-19.|pdf=|usr=008}} | ||
| + | {{tp|p=32410763|t=2020. Acute olfactory loss is specific for Covid-19 at the Emergency Department.|pdf=|usr=008}} | ||
| + | {{tp|p=32516656|t=2020. Clinical characteristics associated with persistent olfactory and taste alterations in COVID-19: A preliminary report on 121 patients.|pdf=|usr=008}} | ||
| + | {{tp|p=32336572|t=2020. New type of corona virus induced acute otitis media in adult.|pdf=|usr=008}} | ||
| + | {{tp|p=32307189|t=2020. Audiological profile of asymptomatic Covid-19 PCR-positive cases.|pdf=|usr=008}} | ||
| + | {{tp|p=32526530|t=2020. COVID-19 sampling from the middle ear and mastoid: A case report.|pdf=|usr=008}} | ||
| + | {{tp|p=32386897|t=2020. Comment on "Hearing loss and COVID-19: A note".|pdf=|usr=008}} | ||
| + | {{tp|p=32471704|t=2020. Central Nervous System Involvement in COVID-19.|pdf=|usr=008}} | ||
| + | {{tp|p=32517875|t=2020. Epidemia COVID-19: inverted question markdebe el oftalmologo estar alerta ante las paresias oculomotoras?|pdf=|usr=008}} | ||
| + | {{tp|p=32404376|t=2020. Hypogeusia as the initial presenting symptom of COVID-19.|pdf=|usr=008}} | ||
| + | {{tp|p=32449883|t=2020. Loss of Smell and Taste in 2013 European Patients With Mild to Moderate COVID-19.|pdf=|usr=008}} | ||
| + | {{tp|p=32533727|t=2020. Report of EEG Finding on Critically Ill Patients with COVID-19.|pdf=|usr=008}} | ||
| + | {{tp|p=32468830|t=2020. Taste and Smell Dysfunction in COVID-19 Patients.|pdf=|usr=008}} | ||
| + | {{tp|p=32530389|t=2020. SARS-CoV-2 infection of the nervous system: A review of the literature on neurological involvement in novel coronavirus disease (COVID-19).|pdf=|usr=008}} | ||
| + | {{tp|p=32479992|t=2020. Identifying causal role of COVID-19 in immunopsychiatry models.|pdf=|usr=008}} | ||
| + | {{tp|p=32497777|t=2020. The neuroinvasive potential of severe acute respiratory syndrome coronavirus 2.|pdf=|usr=008}} | ||
| + | {{tp|p=32416289|t=2020. Subjective neurological symptoms frequently occur in patients with SARS-CoV2 infection.|pdf=|usr=008}} | ||
| + | {{tp|p=32425332|t=2020. Neuroleptic malignant syndrome in a COVID-19 patient.|pdf=|usr=008}} | ||
| + | {{tp|p=32531427|t=2020. Delirium as a presenting feature in COVID-19: neuroinvasive infection or autoimmune encephalopathy?|pdf=|usr=008}} | ||
| + | {{tp|p=32525049|t=2020. Intracerebral haemorrhage and COVID-19: Clinical characteristics from a case series.|pdf=|usr=008}} | ||
| + | {{ttp|p=32497778|t=2020. A pharmacological interactome between COVID-19 patient samples and human sensory neurons reveals potential drivers of neurogenic pulmonary dysfunction.|pdf=|usr=008}} | ||
| + | {{tp|p=32534982|t=2020. Incomplete and late recovery of sudden olfactory dysfunction in COVID-19.|pdf=|usr=008}} | ||
| + | {{tp|p=32518103|t=2020. Guillain-Barre syndrome associated with leptomeningeal enhancement following SARS-CoV-2 infection.|pdf=|usr=008}} | ||
| + | {{tp|p=32524707|t=2020. Smell and taste disorders during COVID-19 outbreak: A cross-sectional study on 355 patients.|pdf=|usr=008}} | ||
| + | {{tp|p=32521062|t=2020. Headache as the Presenting Symptom in 2 Patients with COVID-19 and a History of Migraine: 2 Case Reports.|pdf=|usr=008}} | ||
| + | {{tp|p=32521039|t=2020. COVID-19 and Headache: A Primer for Trainees.|pdf=|usr=008}} | ||
| + | {{tp|p=32530326|t=2020. Does coronavirus affect the audio-vestibular system? A rapid systematic review.|pdf=|usr=008}} | ||
| + | {{tp|p=32533876|t=2020. Guillain-Barre syndrome after SARS-CoV-2 infection.|pdf=|usr=008}} | ||
| + | {{tp|p=32531083|t=2020. Guillain-Barre syndrome in a patient with antibodies against SARS-COV-2.|pdf=|usr=008}} | ||
| + | {{tp|p=32526073|t=2020. Novel corona virus (COVID-19) disease and ophthalmic manifestations: Clinical evidences.|pdf=|usr=008}} | ||
| + | {{tp|p=32454137|t=2020. Anti-NMDA receptor encephalitis in a psychiatric Covid-19 patient: A case report.|pdf=|usr=008}} | ||
| + | {{tp|p=32445789|t=2020. Is COVID-19-related Guillain-Barre syndrome different?|pdf=|usr=008}} | ||
| + | {{tp|p=32382727|t=2020. THE IMPACT OF COVID-19 ON MENTAL HEALTH: THE INTERACTIVE ROLES OF BRAIN BIOTYPES AND HUMAN CONNECTION.|pdf=|usr=008}} | ||
| + | {{tp|p=32427134|t=2020. HOW TO DETECT AND TRACK CHRONIC NEUROLOGIC SEQUELAE OF COVID-19? USE OF AUDITORY BRAINSTEM RESPONSES AND NEUROIMAGING FOR LONG-TERM PATIENT FOLLOW-UP.|pdf=|usr=008}} | ||
| + | {{tp|p=32447049|t=2020. Anosmia in COVID-19 patients.|pdf=|usr=008}} | ||
| + | {{tp|p=32406140|t=2020. The ocular surface, coronaviruses and COVID-19.|pdf=|usr=008}} | ||
| + | {{tp|p=32396988|t=2020. COVID-19, sweat, tears... and myopia?|pdf=|usr=008}} | ||
| + | {{tp|p=32502645|t=2020. New-onset anosmia and ageusia in adult patients diagnosed with SARS-CoV-2 infection.|pdf=|usr=008}} | ||
| + | {{tp|p=32525467|t=2020. COVID-19 and Acute Ischemic Stroke- A Case Series from Dubai, UAE.|pdf=|usr=008}} | ||
| + | {{tp|p=32422545|t=2020. Neurological manifestations of COVID-19 and other coronavirus infections: A systematic review.|pdf=|usr=008}} | ||
| + | {{tp|p=32405258|t=2020. Non-lesional status epilepticus in a patient with coronavirus disease 2019.|pdf=|usr=008}} | ||
| + | {{tp|p=32422529|t=2020. Post SARS-CoV-2 Guillain-Barre syndrome.|pdf=|usr=008}} | ||
| + | {{tp|p=32458242|t=2020. Can COVID-19 cause myalgia with a completely different mechanism? A hypothesis.|pdf=|usr=008}} | ||
| + | {{tp|p=32531174|t=2020. New Insights for the Pathogenesis of COVID-19-Related Dysgeusia.|pdf=|usr=008}} | ||
| + | {{tp|p=32499974|t=2020. Neurological Complications of Coronavirus Disease (COVID-19): Encephalopathy, MRI Brain and Cerebrospinal Fluid Findings: Case 2.|pdf=|usr=008}} | ||
| + | {{tp|p=32455089|t=2020. A Review of Neurological Complications of COVID-19.|pdf=|usr=008}} | ||
| + | {{tp|p=32426749|t=2020. Neurologic Manifestations of Severe Respiratory Viral Contagions.|pdf=|usr=008}} | ||
| + | {{tp|p=32428084|t=2020. Fonoaudiologia, amamentacao e COVID-19: informacoes aos fonoaudiologos.|pdf=|usr=008}} | ||
| + | {{tp|p=32422426|t=2020. Importance of SARs-Cov-2 anosmia: From phenomenology to neurobiology.|pdf=|usr=008}} | ||
| + | {{tp|p=32426200|t=2020. Encephalopathy as the Sentinel Sign of a Cortical Stroke in a Patient Infected With Coronavirus Disease-19 (COVID-19).|pdf=|usr=008}} | ||
| + | {{tp|p=32528783|t=2020. Neurological and Psychological Effects of Coronavirus (COVID-19): An Overview of the Current Era Pandemic.|pdf=|usr=008}} | ||
| + | {{tp|p=32494532|t=2020. Anosmia and Ageusia as the Only Indicators of Coronavirus Disease 2019 (COVID-19).|pdf=|usr=008}} | ||
| + | {{tp|p=32489724|t=2020. Basal Ganglia Involvement and Altered Mental Status: A Unique Neurological Manifestation of Coronavirus Disease 2019.|pdf=|usr=008}} | ||
| + | {{tp|p=32483497|t=2020. Novel Coronavirus Disease 2019 and Subarachnoid Hemorrhage: A Case Report.|pdf=|usr=008}} | ||
| + | {{tp|p=32535934|t=2020. COVID-19 associated myositis with severe proximal and bulbar weakness.|pdf=|usr=008}} | ||
| + | {{tp|p=32521557|t=2020. Riechstorungen bei COVID-19 - aktueller Wissensstand.|pdf=|usr=008}} | ||
| + | {{tp|p=32534336|t=2020. COVID-19 & Periodontitis: The cytokine connection.|pdf=|usr=008}} | ||
| + | {{tp|p=32515379|t=2020. Neurological manifestations of COVID-19.|pdf=|usr=008}} | ||
| + | {{tp|p=32474399|t=2020. Infectivity of human coronavirus in the brain.|pdf=|usr=008}} | ||
| + | {{tp|p=32468193|t=2020. Postintubation Dysphagia During COVID-19 Outbreak-Contemporary Review.|pdf=|usr=008}} | ||
| + | {{tp|p=32533346|t=2020. Oropharyngeal Dysphagia and Aspiration Pneumonia Following Coronavirus Disease 2019: A Case Report.|pdf=|usr=008}} | ||
| + | {{tp|p=32304092|t=2020. New onset acute symptomatic seizure and risk factors in coronavirus disease 2019: A retrospective multicenter study.|pdf=|usr=008}} | ||
| + | {{tp|p=32491984|t=2020. Parotitis-Like Symptoms Associated with COVID-19, France, March-April 2020.|pdf=|usr=008}} | ||
| + | {{tp|p=32489743|t=2020. COVID-19 Pandemic: A Neurological Perspective.|pdf=|usr=008}} | ||
| + | {{tp|p=32399457|t=2020. Cerebral Venous Sinus Thrombosis as a Presentation of COVID-19.|pdf=|usr=008}} | ||
| + | {{tp|p=32524689|t=2020. Overlapping findings or oral manifestations in new SARS-CoV-2 infection?|pdf=|usr=008}} | ||
| + | {{ttp|p=32523929|t=2020. Respiratory Distress in SARS-CoV-2 without Lung Damage: Phrenic Paralysis Should Be Considered in COVID-19 Infection.|pdf=|usr=008}} | ||
| + | {{tp|p=32516281|t=2020. ANOSMIA AND AGEUSIA: NOT AN UNCOMMON PRESENTATION OF COVID-19 INFECTION IN CHILDREN AND ADOLESCENTS.|pdf=|usr=008}} | ||
| + | {{tp|p=32396710|t=2020. COVID-19 and neurodegeneration: what can we learn from the past?|pdf=|usr=008}} | ||
| + | {{tp|p=32383343|t=2020. Two patients with acute meningoencephalitis concomitant with SARS-CoV-2 infection.|pdf=|usr=008}} | ||
| + | {{tp|p=32463341|t=2020. COVID-19 and Eye Problems.|pdf=|usr=008}} | ||
| + | {{tp|p=32513065|t=2020. Persistent Smell Loss Following Undetectable SARS-CoV-2.|pdf=|usr=008}} | ||
| + | {{tp|p=32513055|t=2020. Comment on "The Prevalence of Olfactory and Gustatory Dysfunction in COVID-19 Patients: A Systematic Review and Meta-analysis".|pdf=|usr=008}} | ||
| + | {{tp|p=32470824|t=2020. Delirium in COVID-19: A case series and exploration of potential mechanisms for central nervous system involvement.|pdf=|usr=008}} | ||
| + | {{tp|p=32424329|t=2020. Detection of severe acute respiratory syndrome Coronavirus-2 in the tears of patients with Coronavirus disease 2019.|pdf=|usr=008}} | ||
| + | {{tp|p=32424327|t=2020. Coronavirus disease 2019 (SARS-CoV-2) and colonization of ocular tissues and secretions: a systematic review.|pdf=|usr=008}} | ||
| + | {{tp|p=32474035|t=2020. COVID-19 and the Eye.|pdf=|usr=008}} | ||
| − | {{tp|p= | + | {{tp|p=32283878|t=2020. [Whether conjunctival congestion in patients infected with 2019 novel coronavirus is definitely related the novel coronavirus?]|pdf=|usr=008}} |
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | {{tp|p= | + | {{tp|p=32357379|t=2020. Validation of a self-administered olfactory and gustatory test for the remotely evaluation of COVID-19 patients in home quarantine.|pdf=|usr=008}} |
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | {{tp|p= | + | {{tp|p=32515675|t=2020. Neurological Involvement of COVID-19 Patients: Making the Most of MRI.|pdf=|usr=008}} |
| − | {{tp|p= | + | {{tp|p=32533768|t=2020. Time scale for resolution of olfactory dysfunction in COVID-19.|pdf=|usr=008}} |
| − | {{tp|p= | + | {{tp|p=32437002|t=2020. Is the brain a reservoir organ for SARS-CoV2?|pdf=|usr=008}} |
| − | {{tp|p= | + | {{tp|p=32383370|t=2020. Prevalence and Duration of Acute Loss of Smell or Taste in COVID-19 Patients.|pdf=|usr=008}} |
| − | {{tp|p= | + | {{tp|p=32476306|t=2020. Olfactory and Gustatory Dysfunction in a COVID-19 Patient with Ankylosing Spondylitis Treated with Etanercept: Case Report.|pdf=|usr=008}} |
| − | {{tp|p= | + | {{tp|p=32383776|t=2020. Patient Follow-up after Discharge after COVID-19 Pneumonia: Considerations for Infectious Control.|pdf=|usr=008}} |
| − | {{tp|p= | + | {{tp|p=32383264|t=2020. Comment on "Central Nervous System Involvement by Severe Acute Respiratory Syndrome Coronavirus -2 (SARS-CoV-2)".|pdf=|usr=008}} |
| − | {{tp|p= | + | {{tp|p=32383174|t=2020. High prevalence of olfactory and taste disorder during SARS-CoV-2 infection in outpatients.|pdf=|usr=008}} |
| − | {{tp|p= | + | {{tp|p=32401352|t=2020. Update on the neurology of COVID-19.|pdf=|usr=008}} |
| − | {{tp|p= | + | {{tp|p=32451846|t=2020. Does SARS-CoV-2 infection cause chronic neurological complications?|pdf=|usr=008}} |
| − | {{tp|p= | + | {{tp|p=32398850|t=2020. Care for critically Ill patients with COVID-19: don't forget the eyes.|pdf=|usr=008}} |
| + | {{tp|p=32521067|t=2020. Oral manifestations in COVID-19 patients.|pdf=|usr=008}} | ||
| + | {{tp|p=32526743|t=2020. COVID-19-Related Stroke: Barking up the Wrong Tree?|pdf=|usr=008}} | ||
| + | {{tp|p=32396239|t=2020. The impact of laryngopharyngeal reflux disease on 95 hospitalized patients with COVID-19 in Wuhan, China: A retrospective study.|pdf=|usr=008}} | ||
| + | {{tp|p=32494854|t=2020. A review of pathophysiology and neuropsychiatric manifestations of COVID-19.|pdf=|usr=008}} | ||
| + | {{tp|p=32462348|t=2020. Onset of Covid-19 with impaired consciousness and ataxia: a case report.|pdf=|usr=008}} | ||
| + | {{tp|p=32458198|t=2020. Acute transverse myelitis after COVID-19 pneumonia.|pdf=|usr=008}} | ||
| + | {{tp|p=32458197|t=2020. Neurological manifestations of COVID-19: a review of what we know so far.|pdf=|usr=008}} | ||
| + | {{tp|p=32458195|t=2020. Miller-Fisher-like syndrome related to SARS-CoV-2 infection (COVID 19).|pdf=|usr=008}} | ||
| + | {{tp|p=32458194|t=2020. Non-epileptic seizures in autonomic dysfunction as the initial symptom of COVID-19.|pdf=|usr=008}} | ||
| + | {{tp|p=32458193|t=2020. Understanding the neurotropic characteristics of SARS-CoV-2: from neurological manifestations of COVID-19 to potential neurotropic mechanisms.|pdf=|usr=008}} | ||
| + | {{tp|p=32458192|t=2020. Post-infectious Guillain-Barre syndrome related to SARS-CoV-2 infection: a case report.|pdf=|usr=008}} | ||
| + | {{tp|p=32451613|t=2020. Quantitative evaluation of olfactory dysfunction in hospitalized patients with Coronavirus [2] (COVID-19).|pdf=|usr=008}} | ||
| + | {{tp|p=32436105|t=2020. Stroke in patients with SARS-CoV-2 infection: case series.|pdf=|usr=008}} | ||
| + | {{tp|p=32430572|t=2020. Guillain-Barre syndrome in the COVID-19 era: just an occasional cluster?|pdf=|usr=008}} | ||
| + | {{tp|p=32399694|t=2020. Acute polyradiculoneuritis with locked-in syndrome in a patient with Covid-19.|pdf=|usr=008}} | ||
| + | {{tp|p=32529462|t=2020. May the Central Nervous System Be Fogged by the Cytokine Storm in COVID-19?: an Appraisal.|pdf=|usr=008}} | ||
| + | {{tp|p=32447746|t=2020. SARS-CoV-2 Infection Leads to Neurological Dysfunction.|pdf=|usr=008}} | ||
| + | {{tp|p=32474657|t=2020. COVID-19-associated acute disseminated encephalomyelitis (ADEM).|pdf=|usr=008}} | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | {{tp|p= | + | {{tp|p=32275082|t=2020. Conjunctiva is not a preferred gateway of entry for SARS-CoV-2 to infect respiratory tract.|pdf=|usr=008}} |
| − | {{tp|p= | + | |
| − | {{tp|p= | + | |
| − | {{tp|p= | + | {{tp|p=32533322|t=2020. Mixed central and peripheral nervous system disorders in severe SARS-CoV-2 infection.|pdf=|usr=008}} |
| − | {{tp|p= | + | {{tp|p=32533321|t=2020. Isolated post SARS-CoV-2 diplopia.|pdf=|usr=008}} |
| − | {{tp|p= | + | {{tp|p=32529577|t=2020. COVID-19 encephalopathy: detection of antibodies against SARS-CoV-2 in CSF.|pdf=|usr=008}} |
| + | {{tp|p=32529575|t=2020. Clinical manifestations and evidence of neurological involvement in 2019 novel coronavirus SARS-CoV-2: a systematic review and meta-analysis.|pdf=|usr=008}} | ||
| + | {{tp|p=32494853|t=2020. Neurological complications of COVID-19: a preliminary review.|pdf=|usr=008}} | ||
| + | {{tp|p=32436101|t=2020. Neurological manifestations associated with COVID-19: a review and a call for action.|pdf=|usr=008}} | ||
| + | {{tp|p=32531579|t=2020. Serotonin syndrome in two COVID-19 patients treated with lopinavir/ritonavir.|pdf=|usr=008}} | ||
| + | {{tp|p=32480073|t=2020. COVID-19-associated delayed posthypoxic necrotizing leukoencephalopathy.|pdf=|usr=008}} | ||
| + | {{tp|p=32474220|t=2020. COVID-19-associated mild encephalitis/encephalopathy with a reversible splenial lesion.|pdf=|usr=008}} | ||
| + | {{tp|p=32532449|t=2020. Part I. SARS-CoV-2 triggered 'PANIC' attack in severe COVID-19.|pdf=|usr=008}} | ||
| + | {{tp|p=32474362|t=2020. Posterior reversible encephalopathy syndrome (PRES) as a neurological association in severe Covid-19.|pdf=|usr=008}} | ||
| + | {{tp|p=32447193|t=2020. COVID-19 related neuroimaging findings: A signal of thromboembolic complications and a strong prognostic marker of poor patient outcome.|pdf=|usr=008}} | ||
| + | {{tp|p=32444286|t=2020. Brain imaging findings in COVID-19: What do we know so far?|pdf=|usr=008}} | ||
| + | {{tp|p=32417159|t=2020. Neuroradiological features in COVID-19 patients: First evidence in a complex scenario.|pdf=|usr=008}} | ||
| + | {{tp|p=32437707|t=2020. Cerebral venous thrombosis associated with COVID-19 infection: Causality or coincidence?|pdf=|usr=008}} | ||
| + | {{tp|p=32424616|t=2020. A special symptom of olfactory dysfunction in coronavirus disease 2019: report of three cases.|pdf=|usr=008}} | ||
| + | |||
| + | {{tp|p=32418055|t=2020. COVID-19 virus may have neuroinvasive potential and cause neurological complications: a perspective review.|pdf=|usr=008}} | ||
| + | {{tp|p=32529516|t=2020. Miller Fisher syndrome diagnosis and treatment in a patient with SARS-CoV-2.|pdf=|usr=008}} | ||
| + | {{tp|p=32447630|t=2020. COVID-19 and the nervous system.|pdf=|usr=008}} | ||
| + | {{tp|p=32423471|t=2020. Musculoskeletal symptoms in SARS-CoV-2 (COVID-19) patients.|pdf=|usr=008}} | ||
Aktuelle Version vom 12. September 2020, 17:22 Uhr
coviki.org collects the really good Ideas and the scientific Record on Covid-19 Virus.
D further streaming-in related content is here
- Cerebral embolism
- Cerebral Haemorrhage
- Smell and taste disorder
- Brain infection Neurotropism
- Guillain-Barre Syndrome
- Autoimmune Neuropathies
- Neurology Reviews and Multitopic
- The morbid survivor late sequelae
32415003 2020. Do SARS-CoV2 viral proteins have neuromodulatory properties?
32490972 2020. COVID-19 and the eye: how much do we really know? A best evidence review.
32443834 2020. Specific EEG Encephalopathy Pattern in SARS-CoV-2 Patients.
| 32348111 ä. Is the Collapse of the Respiratory Center in the Brain Responsible for Respiratory Breakdown in COVID-19 Patients? |
32322822 ä. THREE INSIGHTS ON PSYCHONEUROIMMUNOLOGY OF MOOD DISORDERS TO BE TAKEN FROM THE COVID-19 PANDEMIC
32328364 ä. Neurological Complications of Coronavirus Disease (COVID-19): Encephalopathy
32370982 ä. Ensuring mental health care during the SARS-CoV-2 epidemic in France: a narrative review
32363146 2020. COVID-19 Presenting with Seizures
32307298 ä. Severe cerebral involvement in adult-onset hemophagocytic lymphohistiocytosis
32232433 2020. Characteristics of Ocular Findings of Patients With Coronavirus Disease 2019 (COVID-19) in Hubei Province, China
32344366 2020. Focal status epilepticus as unique clinical feature of COVID-19: A case report
32478706 2020. Severe COVID-19 Cases: Is Respiratory Distress Partially Explained by Central Nervous System Involvement?
32374367 ä. Delirium: a missing piece in the COVID-19 pandemic puzzle
32333819 2020. COVID-19: what if the brain had a role in causing the deaths?
| 32301553 2020. Lack of dyspnea in patients with Covid-19: another neurological conundrum? |
| 32246784 ä. An alteration of the dopamine synthetic pathway is possibly involved in the pathophysiology of COVID?19 |
32246782 2020. Respiratory failure alone does not suggest central nervous system invasion by SARS-CoV-2
32291797 2020. SARS-CoV-2: At the Crossroad Between Aging and Neurodegeneration
| 32388138 2020. Hypothesized behavioral host manipulation by SARS-CoV2/COVID-19 infection |
32342265 ä. Coronavirus disease 2019 and obstructive sleep apnea syndrome
32457227 2020. COVID-19-related acute necrotizing encephalopathy with brain stem involvement in a patient with aplastic anemia.
32390132 2020. Trombosis venosa cerebral e infeccion por SARS-CoV-2.
32482781 2020. Acute disseminated encephalomyelitis after SARS-CoV-2 infection.
32461235 2020. Guillain-Barre syndrome related to SARS-CoV-2 infection.
32444427 2020. COVID-19-White matter and globus pallidum lesions: Demyelination or small-vessel vasculitis?
32386285 2020. Anosmia as a presenting symptom of SARS-CoV-2 infection in healthcare workers - A systematic review of the literature, case series, and recommendations for clinical assessment and management.
32352450 2020. Sniffing out the evidence; It's now time for public health bodies recognize the link between COVID-19 and smell and taste disturbance.
32463395 2020. The involvement of the central nervous system in patients with COVID-19.
32355007 2020. The mystery of the pandemic's 'happy hypoxia'.
32286214 2020. [Possible unregistered SARS-CoV-2 infection in a young man with anosmia and ageusia].
32400371 2020. [Anosmia and ageusia as primary symptoms of COVID-19].
32476394 2020. Otorinolaringologicheskie aspekty techeniya zabolevaniya u detei, infitsirovannykh virusom SARS-CoV-2.
32468632 2020. Olfactory dysfunction in recovered COVID-19 patients.
32512352 2020. Affective psychosis after COVID-19 infection in a previously healthy patient: a case report.
32442268 2020. Stroke in a young COVID -19 patient.
32484418 2020. Focal Cerebral Arteriopathy in a COVID-19 Pediatric Patient.
32437314 2020. COVID-19 -associated Diffuse Leukoencephalopathy and Microhemorrhages.
32437313 2020. Imaging in Neurological Disease of Hospitalized COVID-19 Patients: An Italian Multicenter Retrospective Observational Study.
32407258 2020. COVID-19-Associated Leukoencephalopathy.
32510821 2020. Oral cavity lesions as a manifestation of the novel virus (COVID-19): a letter-to-editor.
32506730 2020. Oral Manifestations in Coronavirus Disease 2019 (COVID-19).
32506662 2020. Necrotizing periodontal disease: oral manifestation of COVID-19.
32419568 2020. Orbital cellulitis, sinusitis and intracranial abnormalities in two adolescents with COVID-19.
32453685 2020. Acute Cerebral Stroke with Multiple Infarctions and COVID-19, France, 2020.
32490966 2020. Neurological complications in patients with SARS-CoV-2 infection: a systematic review.
32469246 2020. Psychophysical Olfactory Tests and Detection of COVID-19 in Patients With Sudden Onset Olfactory Dysfunction: A Prospective Study.
32436441 2020. Anosmia Is a Key Symptom of COVID-19 Infection and Should Be Used as a Diagnostic Tool.
32423359 2020. Subjective Changes in Smell and Taste During the COVID-19 Pandemic: A National Survey-Preliminary Results.
32423285 2020. Aggregate Prevalence of Chemosensory and Sinonasal Dysfunction in SARS-CoV-2 and Related Coronaviruses.
32502296 2020. SARS-CoV2 as a potential trigger of neurodegenerative diseases.
32502289 2020. SARS-CoV-2 as a trigger of neurodegeneration: thinking ahead.
32348051 2020. Anosmie et COVID-19.
32501861 2020. Considering the potential for an increase in chronic pain following the COVID-19 pandemic.
32404789 2020. Neonatal Early-Onset Infection With SARS-CoV-2 in a Newborn Presenting With Encephalitic Symptoms.
32468450 2020. New clinical manifestation of COVID-19 related Guillain-Barre syndrome highly responsive to intravenous immunoglobulins: two Italian cases.
32444493 2020. Clinical characteristics and outcomes of inpatients with neurologic disease and COVID-19 in Brescia, Lombardy, Italy.
32444492 2020. Bilateral transient olfactory bulbs edema during COVID-19-related anosmia.
32439822 2020. Pearls and Oy-sters: Facial nerve palsy as a neurological manifestation of Covid-19 infection.
32439821 2020. Generalized myoclonus in COVID-19.
32487714 2020. Cranial Neuropathies and COVID-19: Neurotropism and Autoimmunity.
32482845 2020. Neurologic manifestations in hospitalized patients with COVID-19: The ALBACOVID registry.
32424429 2020. Neurologically Devastating Intraparenchymal Hemorrhage in COVID-19 Patients on Extracorporeal Membrane Oxygenation: A Case Series.
32496534 2020. Letter: Thrombotic Neurovascular Disease in COVID-19 Patients.
32490520 2020. Letter: Hemorrhagic Conditions Affecting the Central Nervous System in COVID-19 Patients.
| 32392566 2020. The Hidden Face of Fear in the COVID-19 Era: The Amygdala Hijack. |
32487282 2020. Encephalopathy and Encephalitis Associated with Cerebrospinal Fluid Cytokine Alterations and Coronavirus Disease, Atlanta, Georgia, USA, 2020.
32445201 2020. SARS-CoV-2-associated Guillain-Barre syndrome with dysautonomia.
32505222 2020. Early evidence of pronounced brain involvement in fatal COVID-19 outcomes.
32503883 2020. Defining causality in COVID-19 and neurological disorders.
32507577 2020. COVID-19 and Cerebral Hemorrhage: Proposed Mechanisms.
32458578 2020. COVID-19 encephalopathy masquerading as substance withdrawal.
32453517 2020. More on Neurologic Features in Severe SARS-CoV-2 Infection. Reply.
32453516 2020. More on Neurologic Features in Severe SARS-CoV-2 Infection.
32453515 2020. More on Neurologic Features in Severe SARS-CoV-2 Infection.
32497292 2020. Guillain-Barre Syndrome in a Patient with Minimal Symptoms of COVID-19 Infection.
32432682 2020. Olfactory Dysfunction in COVID-19: Diagnosis and Management.
32469387 2020. Neuropathogenesis and Neurologic Manifestations of the Coronaviruses in the Age of Coronavirus Disease 2019: A Review.
32497288 2020. COVID-19 polyradiculitis in 24 patients without SARS-CoV-2 in the cerebro-spinal fluid.
32504746 2020. SARS-CoV-2 RNA detection in tears and conjunctival secretions of COVID-19 patients with conjunctivitis.
32427357 2020. Encephalopathy in patients with COVID-19: 'Causality or coincidence?'
32418237 2020. Hypoxemia in COVID-19; Comment on: "The neuroinvasive potential of SARS - CoV2 may play a role in the respiratory failure of COVID-19 patients".
32484990 2020. First Case of Focal Epilepsy Associated with SARS-Coronavirus-2.
32451359 2020. Stroke and mechanical thrombectomy in patients with COVID-19: technical observations and patient characteristics.
32492193 2020. Potential Neuroinvasive Pathways of SARS-CoV-2: Deciphering the Spectrum of Neurological Deficit Seen in Coronavirus Disease 2019 (COVID-19).
32504100 2020. Ocular manifestations of coronavirus disease 2019.
32437033 2020. Objective olfactory evaluation of self-reported loss of smell in a case series of 86 COVID-19 patients.
32437022 2020. Olfactory and gustatory function impairment in COVID-19 patients: Italian objective multicenter-study.
32507468 2020. Measuring grip strength in COVID-19: A simple way to predict overall frailty/impairment.
32461325 2020. Anosmia and dysgeusia associated with SARS-CoV-2 infection: an age-matched case-control study.
32406374 2020. Olfactory dysfunction in the COVID-19 outbreak.
32505878 2020. Patients with COVID-19 and neurological manifestations show undetectable SARS-CoV-2 RNA levels in the cerebrospinal fluid.
32412510 2020. Neurological manifestations of COVID-19.
32398625 2020. Coincidence of COVID-19 Infection and Smell: Taste Perception Disorders.
32505431 2020. Neuroimmune correlates of the nervous system involvement of COVID-19: A commentary.
32505432 2020. Does COVID-19 cause axonal GBS?
32436835 2020. Isolated Anosmia as a Presentation of COVID-19: An Experience in a Referral Hospital.
32408926 2020. Fallout from the Covid-19 pandemic - should we prepare for a tsunami of post viral depression?
32501751 2020. EXPRESS: Brain ischemic and hemorrhagic complications of COVID-19.
32497397 2020. Psychophysical olfactory testing in COVID-19: is smell function really impaired in nearly all patients?
32496658 2020. Reply to: Psychophysical olfactory testing in COVID-19: Is smell function really impaired in nearly all patients?
32503820 2020. Ocular Manifestations of COVID-19 (SARS-CoV-2): A Critical Review of Current Literature.
32441248 2020. The impact of SARS-CoV-2 on sleep.
32507123 2020. Self-reported anosmia and dysgeusia as key symptoms of COVID-19.
32478675 2020. Headache is an important symptom in patients with coronavirus disease 2019 (COVID-19).
32460415 2020. Dysphagia in COVID-19 -multilevel damage to the swallowing network?
32433817 2020. Prolonged Confusional state as first manifestation of COVID-19.
32503088 2020. A systematic review of neurological manifestations of SARS-CoV-2 infection: the devil is hidden in the details.
32503084 2020. Miller-Fisher syndrome after SARS-CoV-2 infection.
32503080 2020. Concomitant brain arterial and venous thrombosis in a COVID-19 patient.
32492256 2020. How to support the quality of life of people living with cognitive disorders? A (k)new challenge in the post-Covid World.
32478936 2020. SARS-CoV-2 and Guillain-Barre syndrome: AIDP variant with favorable outcome.
32450718 2020. Ophthalmology and SARS-CoV-2: Blind toward those who fight blindness?
32443166 2020. Letter to the Editor about the Beltran-Corbellini et al. publication :"Acute-onset smell and taste disorders in the context of Covid-19: a pilot multicenter PCR-based case-control study" (Eur J Neurol. 2020. doi: 10.1111/ene.14273.).
32449247 2020. Reply to letter: Acute-onset smell and taste disorders in the context of Covid-19: a pilot multicenter PCR-based case-control study.
32416028 2020. Neurological manifestations and neuro-invasive mechanisms of the severe acute respiratory syndrome coronavirus type 2.
32468862 2020. L..: malignant MCA infarct in a patient with COVID 19 infection.
32463454 2020. Alterations in smell or taste - Classic COVID-19?
32436625 2020. Low risk of SARS-CoV-2 transmission through the ocular surface.
32484130 2020. COVID-19 associated central nervous system vasculopathy.
32474587 2020. COVID-19: Possible reasons for the increased prevalence of Olfactory and Gustatory dysfunction observed in European studies.
32491829 2020. SARS-CoV-2 more than a respiratory virus: Its potential role in neuropathogenesis.
32421258 2020. Ocular manifestations and clinical characteristics of 535 cases of COVID-19 in Wuhan, China: a cross-sectional study.
32403983 2020. Neurotropic mechanisms in COVID-19 and their potential influence on neuropsychological outcomes in children.
32468972 2020. Guillain-Barre syndrome with facial diplegia related to SARS-CoV-2 infection.
32493536 2020. COVID-19 presenting with thalamic hemorrhage unmasking moyamoya angiopathy.
32473022 2020. Coronavirus disease-2019 in pregnancy with neurological manifestations versus pregnancy with eclampsia: Need for liberal testing to rule out the masquerades.
32420954 2020. Smell and taste dysfunction during the COVID-19 outbreak: a preliminary report.
32413158 2020. Headaches During COVID-19: My Clinical Case and Review of the Literature.
32470238 2020. Taste and smell as chemosensory dysfunctions in COVID-19 infection.
32451564 2020. Temporare Hyposmie bei COVID-19-Patienten.
32426230 2020. Encephalopathy and seizure activity in a COVID-19 well controlled HIV patient.
32467191 2020. Brain Imaging Use and Findings in COVID-19: A Single Academic Center Experience in the Epicenter of Disease in the United States.
32467190 2020. COVID-19-Associated Miller Fisher Syndrome: MRI Findings.
32467189 2020. Surprise Diagnosis of COVID-19 following Neuroimaging Evaluation for Unrelated Reasons during the Pandemic in Hot Spots.
32439646 2020. Hemorrhagic Posterior Reversible Encephalopathy Syndrome as a Manifestation of COVID-19 Infection.
32409316 2020. Cerebrovascular Disease in COVID-19.
32354715 2020. Neuroradiologists, Be Mindful of the Neuroinvasive Potential of COVID-19.
32483943 2020. Episcleritis as an ocular manifestation in a patient with COVID-19.
32514394 2020. Symmetrical polyneuropathy in coronavirus disease 2019 (COVID-19).
32519260 2020. Thalassemic Child Presenting with Anosmia due to COVID-19.
32461419 2020. Commentary: Exploring the transmission of COVID-19 through the ocular surface.
32461418 2020. Presence of viral RNA of SARS-CoV-2 in conjunctival swab specimens of COVID-19 patients.
32410112 2020. Contribution of anosmia and dysgeusia for diagnostic of COVID-19 in outpatients.
32532937 2020. Neurologic aspects of covid-19: a concise review.
32425285 2020. Retrospective Analysis of Smell and Taste Disturbances Associated with Dermatological Medications Reported to the United States Food and Drug Administration and Relevance to COVID-19 Infections.
32535294 2020. Could sudden sensorineural hearing loss be the sole manifestation of COVID-19? An investigation into SARS-COV-2 in the etiology of sudden sensorineural hearing loss.
32363809 2020. Smell and taste symptom-based predictive model for COVID-19 diagnosis.
32410386 2020. Smell and taste alterations in Covid-19: a cross-sectional analysis of different cohorts.
32395917 2020. Self-reported olfactory loss in COVID-19: is it really a favorable prognostic factor?
32395913 2020. Reply to: Self-reported olfactory loss in COVID-19: is it really a favorable prognostic factor?
32271490 2020. A primer on viral-associated olfactory loss in the era of COVID-19.
32279441 2020. Association of chemosensory dysfunction and COVID-19 in patients presenting with influenza-like symptoms.
32526392 2020. Oral mucosal lesions in a COVID-19 patient: new signs or secondary manifestations?
32531341 2020. Ocular manifestations and viral shedding in tears of pediatric patients with coronavirus disease 2019: a preliminary report.
32410788 2020. Facial diplegia, a possible atypical variant of Guillain-Barre Syndrome as a rare neurological complication of SARS-CoV-2.
32456959 2020. The Ocular Manifestations and Transmission of COVID-19: Recommendations for Prevention.
32453100 2020. Novel Coronavirus (COVID-19)-Associated Guillain-Barre Syndrome: Case Report.
32519322 2020. Self-Reported Loss of Smell and Taste in SARS-CoV-2 Patients: Primary Care Data to Guide Future Early Detection Strategies.
32425479 2020. MRI evaluation of the olfactory clefts in patients with SARS-CoV-2 infection revealed an unexpected mechanism for olfactory function loss.
| 32427468 2020. Autonomic Brain Centers and Pathophysiology of COVID-19. |
32524537 2020. A complication of coronavirus disease 2019: delirium.
32430637 2020. COVID-19-associated meningoencephalitis complicated with intracranial hemorrhage: a case report.
32412088 2020. Neurological Manifestations of COVID-19: A systematic review and current update.
32466862 2020. Alteraciones del olfato en la COVID-19, revision de la evidencia e implicaciones en el manejo de la pandemia.
32527987 2020. Potential mechanisms of hemorrhagic stroke in elderly COVID-19 patients.
32519994 2020. Vertigo and hearing loss during the COVID-19 pandemic - is there an association?
32414522 2020. Weakness and elevated creatinine kinase as the initial presentation of coronavirus disease 2019 (COVID-19).
32506549 2020. COVID-19: A Global Threat to the Nervous System.
32425470 2020. Altered Mental Status as a Novel Initial Clinical Presentation for COVID-19 Infection in the Elderly.
32527141 2020. Prevalence and Recovery From Olfactory and Gustatory Dysfunctions in Covid-19 Infection: A Prospective Multicenter Study.
32473756 2020. Neuroleptic malignant syndrome in patients with COVID-19.
32425321 2020. Neurologic complications of COVID-19.
32530597 2020. Happy Hypoxemia in COVID-19-A Neural Hypothesis.
32531619 2020. Olfactory and gustatory dysfunctions in COVID-19. First reports of Latin-American ethnic patients.
32527845 2020. Evolving Neuroimaging Findings during COVID-19.
32527844 2020. Neurovascular Complications in COVID-19 Infection: Case Series.
32527843 2020. Neuroimaging Findings in Patients with COVID-19.
32527842 2020. Neurologic Involvement in COVID-19: Cause or Coincidence? A Neuroimaging Perspective.
32388880 2020. Guillain-Barre syndrome during SARS-CoV-2 pandemic: A case report and review of recent literature.
32395550 2020. 2019 novel coronavirus pneumonia with onset of dizziness: a case report.
32418288 2020. Steroid-Responsive Encephalitis in Coronavirus Disease 2019.
32395831 2020. Rapid Dissemination of Protocols for Managing Neurology Inpatients with COVID-19.
32419756 2020. Alteration of Consciousness as Initial Presentation in COVID-19: Observation.
32419755 2020. COVID-19 and Epilepsy.
32419754 2020. COVID-19 and Underlying Cerebrovascular Disease: Analysis on Association.
32419753 2020. COVID 19: Neuromuscular Manifestations.
32419751 2020. 2019-NCoV: What Every Neurologist Should Know?
32407609 2020. De Novo Status Epilepticus in patients with COVID-19.
32410763 2020. Acute olfactory loss is specific for Covid-19 at the Emergency Department.
32516656 2020. Clinical characteristics associated with persistent olfactory and taste alterations in COVID-19: A preliminary report on 121 patients.
32336572 2020. New type of corona virus induced acute otitis media in adult.
32307189 2020. Audiological profile of asymptomatic Covid-19 PCR-positive cases.
32526530 2020. COVID-19 sampling from the middle ear and mastoid: A case report.
32386897 2020. Comment on "Hearing loss and COVID-19: A note".
32471704 2020. Central Nervous System Involvement in COVID-19.
32517875 2020. Epidemia COVID-19: inverted question markdebe el oftalmologo estar alerta ante las paresias oculomotoras?
32404376 2020. Hypogeusia as the initial presenting symptom of COVID-19.
32449883 2020. Loss of Smell and Taste in 2013 European Patients With Mild to Moderate COVID-19.
32533727 2020. Report of EEG Finding on Critically Ill Patients with COVID-19.
32468830 2020. Taste and Smell Dysfunction in COVID-19 Patients.
32530389 2020. SARS-CoV-2 infection of the nervous system: A review of the literature on neurological involvement in novel coronavirus disease (COVID-19).
32479992 2020. Identifying causal role of COVID-19 in immunopsychiatry models.
32497777 2020. The neuroinvasive potential of severe acute respiratory syndrome coronavirus 2.
32416289 2020. Subjective neurological symptoms frequently occur in patients with SARS-CoV2 infection.
32425332 2020. Neuroleptic malignant syndrome in a COVID-19 patient.
32531427 2020. Delirium as a presenting feature in COVID-19: neuroinvasive infection or autoimmune encephalopathy?
32525049 2020. Intracerebral haemorrhage and COVID-19: Clinical characteristics from a case series.
| 32497778 2020. A pharmacological interactome between COVID-19 patient samples and human sensory neurons reveals potential drivers of neurogenic pulmonary dysfunction. |
32534982 2020. Incomplete and late recovery of sudden olfactory dysfunction in COVID-19.
32518103 2020. Guillain-Barre syndrome associated with leptomeningeal enhancement following SARS-CoV-2 infection.
32524707 2020. Smell and taste disorders during COVID-19 outbreak: A cross-sectional study on 355 patients.
32521062 2020. Headache as the Presenting Symptom in 2 Patients with COVID-19 and a History of Migraine: 2 Case Reports.
32521039 2020. COVID-19 and Headache: A Primer for Trainees.
32530326 2020. Does coronavirus affect the audio-vestibular system? A rapid systematic review.
32533876 2020. Guillain-Barre syndrome after SARS-CoV-2 infection.
32531083 2020. Guillain-Barre syndrome in a patient with antibodies against SARS-COV-2.
32526073 2020. Novel corona virus (COVID-19) disease and ophthalmic manifestations: Clinical evidences.
32454137 2020. Anti-NMDA receptor encephalitis in a psychiatric Covid-19 patient: A case report.
32445789 2020. Is COVID-19-related Guillain-Barre syndrome different?
32382727 2020. THE IMPACT OF COVID-19 ON MENTAL HEALTH: THE INTERACTIVE ROLES OF BRAIN BIOTYPES AND HUMAN CONNECTION.
32427134 2020. HOW TO DETECT AND TRACK CHRONIC NEUROLOGIC SEQUELAE OF COVID-19? USE OF AUDITORY BRAINSTEM RESPONSES AND NEUROIMAGING FOR LONG-TERM PATIENT FOLLOW-UP.
32447049 2020. Anosmia in COVID-19 patients.
32406140 2020. The ocular surface, coronaviruses and COVID-19.
32396988 2020. COVID-19, sweat, tears... and myopia?
32502645 2020. New-onset anosmia and ageusia in adult patients diagnosed with SARS-CoV-2 infection.
32525467 2020. COVID-19 and Acute Ischemic Stroke- A Case Series from Dubai, UAE.
32422545 2020. Neurological manifestations of COVID-19 and other coronavirus infections: A systematic review.
32405258 2020. Non-lesional status epilepticus in a patient with coronavirus disease 2019.
32422529 2020. Post SARS-CoV-2 Guillain-Barre syndrome.
32458242 2020. Can COVID-19 cause myalgia with a completely different mechanism? A hypothesis.
32531174 2020. New Insights for the Pathogenesis of COVID-19-Related Dysgeusia.
32499974 2020. Neurological Complications of Coronavirus Disease (COVID-19): Encephalopathy, MRI Brain and Cerebrospinal Fluid Findings: Case 2.
32455089 2020. A Review of Neurological Complications of COVID-19.
32426749 2020. Neurologic Manifestations of Severe Respiratory Viral Contagions.
32428084 2020. Fonoaudiologia, amamentacao e COVID-19: informacoes aos fonoaudiologos.
32422426 2020. Importance of SARs-Cov-2 anosmia: From phenomenology to neurobiology.
32426200 2020. Encephalopathy as the Sentinel Sign of a Cortical Stroke in a Patient Infected With Coronavirus Disease-19 (COVID-19).
32528783 2020. Neurological and Psychological Effects of Coronavirus (COVID-19): An Overview of the Current Era Pandemic.
32494532 2020. Anosmia and Ageusia as the Only Indicators of Coronavirus Disease 2019 (COVID-19).
32489724 2020. Basal Ganglia Involvement and Altered Mental Status: A Unique Neurological Manifestation of Coronavirus Disease 2019.
32483497 2020. Novel Coronavirus Disease 2019 and Subarachnoid Hemorrhage: A Case Report.
32535934 2020. COVID-19 associated myositis with severe proximal and bulbar weakness.
32521557 2020. Riechstorungen bei COVID-19 - aktueller Wissensstand.
32534336 2020. COVID-19 & Periodontitis: The cytokine connection.
32515379 2020. Neurological manifestations of COVID-19.
32474399 2020. Infectivity of human coronavirus in the brain.
32468193 2020. Postintubation Dysphagia During COVID-19 Outbreak-Contemporary Review.
32533346 2020. Oropharyngeal Dysphagia and Aspiration Pneumonia Following Coronavirus Disease 2019: A Case Report.
32304092 2020. New onset acute symptomatic seizure and risk factors in coronavirus disease 2019: A retrospective multicenter study.
32491984 2020. Parotitis-Like Symptoms Associated with COVID-19, France, March-April 2020.
32489743 2020. COVID-19 Pandemic: A Neurological Perspective.
32399457 2020. Cerebral Venous Sinus Thrombosis as a Presentation of COVID-19.
32524689 2020. Overlapping findings or oral manifestations in new SARS-CoV-2 infection?
| 32523929 2020. Respiratory Distress in SARS-CoV-2 without Lung Damage: Phrenic Paralysis Should Be Considered in COVID-19 Infection. |
32516281 2020. ANOSMIA AND AGEUSIA: NOT AN UNCOMMON PRESENTATION OF COVID-19 INFECTION IN CHILDREN AND ADOLESCENTS.
32396710 2020. COVID-19 and neurodegeneration: what can we learn from the past?
32383343 2020. Two patients with acute meningoencephalitis concomitant with SARS-CoV-2 infection.
32463341 2020. COVID-19 and Eye Problems.
32513065 2020. Persistent Smell Loss Following Undetectable SARS-CoV-2.
32513055 2020. Comment on "The Prevalence of Olfactory and Gustatory Dysfunction in COVID-19 Patients: A Systematic Review and Meta-analysis".
32470824 2020. Delirium in COVID-19: A case series and exploration of potential mechanisms for central nervous system involvement.
32424329 2020. Detection of severe acute respiratory syndrome Coronavirus-2 in the tears of patients with Coronavirus disease 2019.
32424327 2020. Coronavirus disease 2019 (SARS-CoV-2) and colonization of ocular tissues and secretions: a systematic review.
32474035 2020. COVID-19 and the Eye.
32283878 2020. [Whether conjunctival congestion in patients infected with 2019 novel coronavirus is definitely related the novel coronavirus?]
32357379 2020. Validation of a self-administered olfactory and gustatory test for the remotely evaluation of COVID-19 patients in home quarantine.
32515675 2020. Neurological Involvement of COVID-19 Patients: Making the Most of MRI.
32533768 2020. Time scale for resolution of olfactory dysfunction in COVID-19.
32437002 2020. Is the brain a reservoir organ for SARS-CoV2?
32383370 2020. Prevalence and Duration of Acute Loss of Smell or Taste in COVID-19 Patients.
32476306 2020. Olfactory and Gustatory Dysfunction in a COVID-19 Patient with Ankylosing Spondylitis Treated with Etanercept: Case Report.
32383776 2020. Patient Follow-up after Discharge after COVID-19 Pneumonia: Considerations for Infectious Control.
32383264 2020. Comment on "Central Nervous System Involvement by Severe Acute Respiratory Syndrome Coronavirus -2 (SARS-CoV-2)".
32383174 2020. High prevalence of olfactory and taste disorder during SARS-CoV-2 infection in outpatients.
32401352 2020. Update on the neurology of COVID-19.
32451846 2020. Does SARS-CoV-2 infection cause chronic neurological complications?
32398850 2020. Care for critically Ill patients with COVID-19: don't forget the eyes.
32521067 2020. Oral manifestations in COVID-19 patients.
32526743 2020. COVID-19-Related Stroke: Barking up the Wrong Tree?
32396239 2020. The impact of laryngopharyngeal reflux disease on 95 hospitalized patients with COVID-19 in Wuhan, China: A retrospective study.
32494854 2020. A review of pathophysiology and neuropsychiatric manifestations of COVID-19.
32462348 2020. Onset of Covid-19 with impaired consciousness and ataxia: a case report.
32458198 2020. Acute transverse myelitis after COVID-19 pneumonia.
32458197 2020. Neurological manifestations of COVID-19: a review of what we know so far.
32458195 2020. Miller-Fisher-like syndrome related to SARS-CoV-2 infection (COVID 19).
32458194 2020. Non-epileptic seizures in autonomic dysfunction as the initial symptom of COVID-19.
32458193 2020. Understanding the neurotropic characteristics of SARS-CoV-2: from neurological manifestations of COVID-19 to potential neurotropic mechanisms.
32458192 2020. Post-infectious Guillain-Barre syndrome related to SARS-CoV-2 infection: a case report.
32451613 2020. Quantitative evaluation of olfactory dysfunction in hospitalized patients with Coronavirus [2] (COVID-19).
32436105 2020. Stroke in patients with SARS-CoV-2 infection: case series.
32430572 2020. Guillain-Barre syndrome in the COVID-19 era: just an occasional cluster?
32399694 2020. Acute polyradiculoneuritis with locked-in syndrome in a patient with Covid-19.
32529462 2020. May the Central Nervous System Be Fogged by the Cytokine Storm in COVID-19?: an Appraisal.
32447746 2020. SARS-CoV-2 Infection Leads to Neurological Dysfunction.
32474657 2020. COVID-19-associated acute disseminated encephalomyelitis (ADEM).
32275082 2020. Conjunctiva is not a preferred gateway of entry for SARS-CoV-2 to infect respiratory tract.
32533322 2020. Mixed central and peripheral nervous system disorders in severe SARS-CoV-2 infection.
32533321 2020. Isolated post SARS-CoV-2 diplopia.
32529577 2020. COVID-19 encephalopathy: detection of antibodies against SARS-CoV-2 in CSF.
32529575 2020. Clinical manifestations and evidence of neurological involvement in 2019 novel coronavirus SARS-CoV-2: a systematic review and meta-analysis.
32494853 2020. Neurological complications of COVID-19: a preliminary review.
32436101 2020. Neurological manifestations associated with COVID-19: a review and a call for action.
32531579 2020. Serotonin syndrome in two COVID-19 patients treated with lopinavir/ritonavir.
32480073 2020. COVID-19-associated delayed posthypoxic necrotizing leukoencephalopathy.
32474220 2020. COVID-19-associated mild encephalitis/encephalopathy with a reversible splenial lesion.
32532449 2020. Part I. SARS-CoV-2 triggered 'PANIC' attack in severe COVID-19.
32474362 2020. Posterior reversible encephalopathy syndrome (PRES) as a neurological association in severe Covid-19.
32447193 2020. COVID-19 related neuroimaging findings: A signal of thromboembolic complications and a strong prognostic marker of poor patient outcome.
32444286 2020. Brain imaging findings in COVID-19: What do we know so far?
32417159 2020. Neuroradiological features in COVID-19 patients: First evidence in a complex scenario.
32437707 2020. Cerebral venous thrombosis associated with COVID-19 infection: Causality or coincidence?
32424616 2020. A special symptom of olfactory dysfunction in coronavirus disease 2019: report of three cases.
32418055 2020. COVID-19 virus may have neuroinvasive potential and cause neurological complications: a perspective review.
32529516 2020. Miller Fisher syndrome diagnosis and treatment in a patient with SARS-CoV-2.
32447630 2020. COVID-19 and the nervous system.
32423471 2020. Musculoskeletal symptoms in SARS-CoV-2 (COVID-19) patients.
